Browse > Article
http://dx.doi.org/10.5762/KAIS.2020.21.3.137

Comparative Study on the Regulations about In-Use Stability, and Analysis the In-Use Stability Application on Approved Syrups - Focused on the Guidelines in US, Europe and Korea -  

Park, Onnuri (School of Pharmacy, Sungkyunkwan University)
Jang, Kyoung won (Department of Pharmaceutical Quality, Daewon University College)
Ha, Dong mun (School of Pharmacy, Sungkyunkwan University)
Publication Information
Journal of the Korea Academia-Industrial cooperation Society / v.21, no.3, 2020 , pp. 137-146 More about this Journal
Abstract
Syrup agents are often used after opening, and therefore, there is a high possibility of decreased quality. The Ministry of Food and Drug Safety (MFDS) published guideline on stability testing for pharmaceuticals after opening in December, 2016. We compared guidelines related to the period of use after opening between the United States of America (USA), Europe (EU), and Korea, and we analyzed whether the period of use or storage conditions is stated based on the data of drug approval for 4 dry syrups and 3 large packing syrups before and after the introduction of the guideline. First, in USA and EU, the period of use and storage conditions after opening should be listed on the label on the packaging container (as well as the expiration date), while in Korea, those are included in the area of precautions for use. Second, all of the analyzed drugs were not changed by the guidelines for establishing the new post-opening period of use, and they were only presented for the existing expiration date prior to the establishment of the guideline. Medicines that are used for multiple uses after opening may need improved instructions to ensure that the period of use and storage conditions are listed on the packaging according to stability evaluation after opening.
Keywords
Syrup Agents; Stability After Opening; Use Period; Expiration Date; Storage Condition;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 W. Shin, J. P. Lee, N. Woo, E. S. Lee, N. H. Kim, M. Y. Kim, M. J. Park, "Research on Developing Guideline on Stability Testing for Pharmaceuticals after Opening", MFDS, KOREA, pp. 1-2, 2016
2 Y. R. Park, Y. M. Lee, "The In Used Stability Evaluation of Amoxicillin Potassium Clavulanate Dry Syrup", The Korean Society of Analytical Sciences, Gyeongju, KOREA, pp. 290-290, Nov. 2015. Available From: http://www.dbpia.co.kr/journal/articleDetail?nodeId=NODE06559624 (accessed Sep. 05, 2019)
3 M. J. Park, N. H. Joeng, "Stability Evaluation of Cefaclor Dry Syrup after Opening with Simulation Design", Journal of the Korean Oil Chemists' Society, pp. 151-152 , 2017. Available From: http://scholar.dkyobobook.co.kr/searchDetail.laf?barcode=4010026158212 (accessed Sep. 05, 2019)
4 S. Y. Shin, K. W. Jang, S. H. S, D. M. Ha, "The in-use stability study of multi-use ophthalmic solutions -Focused on Olopatadine, Fluorometholone, Dorzolamide, Timolol-", Journal of the Korea Academia-Industrial cooperation Society, Vol. 20, No. 2, pp. 681-693, 2019. DOI: https://doi.org/10.5762/KAIS.2019.20.2.681   DOI
5 B. Kommanaboyina, C. T. Rhodes, "Trends in Stability Testing, with Emphasis on Stability During Distribution and Storage", Drug Development and Industrial Pharmacy, Vol. 25, No. 7, pp. 857-868, 1999. DOI: https://doi.org/10.1081/DDC-100102246   DOI
6 B. R. Matthews, "Regulatory Aspects of Stability Testing in Europe", Drug Development and Industrial Pharmacy, Vol. 25, No 7, pp. 831-856, 1999. DOI: https://doi.org/10.1081/DDC-100102245   DOI
7 M. H. Ensom, D. Decarie, A. Lakhani, "Stability of Vancomycin in Ora-Sweet and water in Unit-Dose cups and Plastic Bottles at 4 and 25", Can J Hosp Pharm ; Vol. 63, No. 5, pp. 366-372, 2010. DOI: http://dx.doi.org/10.4212/cjhp.v63i5.948
8 H. A. Makeen, S. S. Pancholi, M. S. Ali, M. I. Alam, M. S. Alam, A. M. Redaie, et al. "Shelf life study of extemporaneously prepared omeprazole oral suspension", Saudi J Health Sci, Vol. 7, No. 1, pp. 28-32, 2018. Available from: http://www.saudijhealthsci.org/text.asp?2018/7/1/28/230227 (accessed Sep. 05, 2019)
9 O. A. Abdelazim, R. S. Ali, R. A. Eissa, "In-Use Stability Study of Paracetamol Syrup", Sudan University of Science and Technology, 2016. Available From: http://repository.sustech.edu/handle/123456789/16542 (accessed Sep. 05, 2019)
10 B. Shadi, S. Nahid, N. Rocsanna, K. Farzad, "Stability assessment of isoniazid and rifampin liquid dosage forms in a national referral center for tuberculosis", International Journal of Pharma Sciences and Research, Vol. 6, No. 4, pp. 706-709, 2015, Available From: https://www.ijpsr.info/docs/IJPSR15-06-04-010.pdf (accessed Sep. 05, 2019)
11 Guidance for Industry Drug Stability Guidelines, U.S. Department of Health and Human Services, Food and Drug Administration, CVM, 2008
12 A. C. van der Vossen, I. van der Velde, O. S. N. M. Smeets, et al, "Design and stability study of an oral solution of amlodipine besylate for pediatric patients" European Journal of Pharmaceutical Sciences, Vol. 92, No. 20, pp. 220-223, 2016. DOI: https://doi.org/10.1016/j.ejps.2016.05.019   DOI
13 U.S. Pharmacopoeia National Formulary, USP General Chapters: <1191> Stability Considerations in Dispensing Practice.
14 Note for Guidance on In-use Stability Testing of Human Medicinal Products, EMA, 2001.
15 U.S. Pharmacopoeia National Formulary, USP General Chapters: <795> Pharmaceutical Compounding-Nonsterile Preparations
16 Guidance for Industry Warning Sections of Labeling for Human Prescription Drug and Biological Products-Content and Format, U.S. Department of Health and Human Services, Food and Drug Administration, CDER, CBER, 2011
17 Guideline on Stability Testing for Pharmaceuticals after Opening, MFDS, 2016.
18 U.S. Pharmacopoeia National Formulary, USP General Chapters: <7> Labelling
19 U.S. Pharmacopoeia National Formulary, USP General Chapters: <797> Pharmaceutical Compounding-Sterile Preparations
20 Guidelines for safe use after opening drugs, MFDS, 2016.